BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10963753)

  • 1. Heterogeneous ligand-mediated Ca(++) responses at wt and mutant alpha(2A)-adrenoceptors suggest multiple ligand activation binding sites at the alpha(2A)-adrenoceptor.
    Pauwels PJ; Colpaert FC
    Neuropharmacology; 2000 Aug; 39(11):2101-11. PubMed ID: 10963753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.
    Pauwels PJ; Colpaert FC
    Br J Pharmacol; 2000 Aug; 130(7):1505-12. PubMed ID: 10928951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
    Pauwels PJ; Tardif S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
    Pauwels PJ; Tardif S; Wurch T; Colpaert FC
    J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
    Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions.
    Pauwels PJ; Colpaert FC
    Br J Pharmacol; 2000 Dec; 131(7):1385-90. PubMed ID: 11090111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein activation by putative antagonists at mutant Thr373Lys alpha2A adrenergic receptors.
    Wurch T; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1999 Feb; 126(4):939-48. PubMed ID: 10193774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins.
    Pauwels PJ; Tardif S; Colpaert FC; Wurch T
    Biochem Pharmacol; 2001 May; 61(9):1079-92. PubMed ID: 11301041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.
    Pauwels PJ; Rauly I; Wurch T
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1015-23. PubMed ID: 12649300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha2B-adrenoceptor-Galpha15 fusion proteins.
    Pauwels PJ; Tardif S; Finana F; Wurch T; Colpaert FC
    J Neurochem; 2000 Jan; 74(1):375-84. PubMed ID: 10617142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for protean agonism of RX 831003 at alpha 2A-adrenoceptors by co-expression with different G alpha protein subunits.
    Pauwels PJ; Rauly I; Wurch T; Colpaert FC
    Neuropharmacology; 2002 May; 42(6):855-63. PubMed ID: 12015212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
    Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist efficacy at the alpha2A-adrenoceptor:G alpha15 fusion protein: an analysis based on Ca2+ responses.
    Pauwels PJ; Finana F; Tardif S; Colpaert FC; Wurch T
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):672-9. PubMed ID: 10882043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).
    Brink CB; Wade SM; Neubig RR
    J Pharmacol Exp Ther; 2000 Aug; 294(2):539-47. PubMed ID: 10900230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
    Renouard A; Widdowson PS; Millan MJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse agonist activity at the alpha(2A)-adrenergic receptor.
    Wade SM; Lan K; Moore DJ; Neubig RR
    Mol Pharmacol; 2001 Mar; 59(3):532-42. PubMed ID: 11179449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.
    Cockcroft V; Frang H; Pihlavisto M; Marjamäki A; Scheinin M
    J Neurochem; 2000 Apr; 74(4):1705-10. PubMed ID: 10737629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
    Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An asn to lys polymorphism in the third intracellular loop of the human alpha 2A-adrenergic receptor imparts enhanced agonist-promoted Gi coupling.
    Small KM; Forbes SL; Brown KM; Liggett SB
    J Biol Chem; 2000 Dec; 275(49):38518-23. PubMed ID: 10948191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.